Navigation Links
FlowCardia, Inc. Launches FlowMate(TM) Injector to Optimize Performance of CROSSER(R) CTO Recanalization Catheter

SUNNYVALE, Calif., Oct. 6 /PRNewswire/ -- FlowCardia, Inc., a worldwide leader in the development of endovascular devices for the treatment of chronic total occlusions (CTOs), has launched the FlowMate Injector, which dramatically simplifies central lumen crossing of CTOs using the CROSSER CTO Recanalization Catheter.

FlowMate provides unparalleled convenience by granting full control of the procedure to a physician via a single foot pedal, which initiates FlowMate's precise saline delivery as well as the Generator which activates the CROSSER Catheter. Fixed injector settings are integrated into the FlowMate adding even greater convenience and ease of use. A single IV pole houses both the FlowMate and Generator allowing for complete system integration.

"This is a significant improvement to the CROSSER CTO Recanalization System and it takes most of the learning curve out of the equation," said Dr. Cezar Staniloae of St. Vincent's Hospital in New York. "Set up is fast and using the new system affords me more time to focus on the patient and specifically, crossing the chronic occlusion with the CROSSER Catheter."

"We are excited to add this important product to our portfolio and to see the benefits to physicians and patients through enhanced CROSSER Catheter performance," said Chris Barys, Chief Operating Officer of FlowCardia. "FlowMate allows for complete CROSSER Catheter system integration and puts the power into the physician's hands, even when faced with the most difficult CTOs."

The CROSSER Catheter is a minimally-invasive endovascular device that utilizes high-frequency, mechanical vibration to facilitate passage through blockages in the peripheral and coronary arteries. It is designed as a frontline therapy to enable central lumen crossing of chronically occluded arteries thereby maximizing physicians' therapeutic options. Over 7,500 CROSSER Catheter procedures have been performed to date by physicians around the world.

About FlowCardia, Inc.

FlowCardia, Inc. is a privately held medical device company established in 2002 to design and manufacture a portfolio of endovascular CTO recanalization products. The CROSSER CTO Recanalization Catheter, steerable support catheters, and Porter guidewires comprise a family of tools which enable physicians to quickly cross chronic total occlusions allowing for subsequent balloon angioplasty, atherectomy, and/or stent placement. Additional information is available on the company's web site at:

    PR Contact Info:
    Mark Page
    Sr. Director, Marketing
    FlowCardia, Inc.
    408-617-0352 ext. 301

SOURCE FlowCardia, Inc.

SOURCE FlowCardia, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FlowCardia, Inc. Appoints Chris Barys Senior VP, Sales
2. $16M in stimulus funding launches Seattle as a hub of comparative-effectiveness research in cancer
3. Optical Express Launches Television Advertisement for the Cosmetic Clinic
4. Seidman Law Offices of Chicago Launches New Websites for FELA, Railroad Injury, and Civil Rights Claims
5. Launches Official Portal With Access To Effective And Affordable Mesotherapy Products
6. The American Academy of Family Physicians Launches Consumer Alliance With First Partner: The Coca-Cola Company
7. SAGE launches Genes & Cancer
8. Typhoon Parma: World Vision Launches Relief Efforts in the Philippines, Pre-positions Supplies in Taiwan
9. Crohn's & Colitis Foundation Launches New Web Site to Commence Take Steps Walk Season: Walkers Can Take the Step that Counts Using New Interactive Features
10. As Environmental Regulations Gather on the Horizon, Crothall Services Group Launches Green Initiatives to Assist Hospitals
11. VisionSync Launches a Smart iPhone First Aid App, iMobile Care
Post Your Comments:
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... ... ... Astellas is a pharmaceutical ...
(Date:6/23/2016)... , June 23, 2016 The vast majority ... outpatient dialysis facility.  Treatments are usually 3 times a ... per visit, including travel time, equipment preparation and wait ... but especially grueling for patients who are elderly and ... skilled nursing and rehabilitation centers for some duration of ...
(Date:6/23/2016)... YORK , June 23, 2016 ... waters, but it continues to present great opportunities to ... companies for today: Intrexon Corp. (NYSE: XON ... Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), and ... more about these stocks and receive your complimentary trade ...
Breaking Medicine Technology: